LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 142,227 | 162,686 | 65,926 | 85,235 | 100,757 |
| TOTAL | $144,002 | $164,373 | $67,431 | $86,736 | $102,300 |
| Non-Current Assets | |||||
| PPE Net | 4,585 | 3,614 | 3,145 | 2,566 | 2,257 |
| Other Non-Current Assets | 0 | 20 | 219 | 219 | 217 |
| TOTAL | $4,585 | $3,634 | $3,364 | $2,785 | $2,474 |
| Total Assets | $148,587 | $168,007 | $70,795 | $89,521 | $104,774 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,920 | 4,173 | 6,652 | 1,998 | 2,256 |
| Accrued Expenses | 2,351 | 1,500 | 2,982 | 5,238 | 2,907 |
| TOTAL | $8,271 | $5,673 | $9,758 | $7,236 | $5,163 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 124 | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $8,271 | $5,673 | $9,758 | $7,236 | $5,163 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,123 | 22,123 | 18,262 | 18,254 | 18,254 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -656,680 | -629,951 | -606,711 | -581,824 | -560,573 |
| Other shareholders' equity | 6,643 | 6,643 | 6,643 | 6,643 | 6,643 |
| TOTAL | $140,316 | $162,334 | $61,037 | $82,285 | $99,611 |
| Total Liabilities And Equity | $148,587 | $168,007 | $70,795 | $89,521 | $104,774 |